Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

The ACR Asks Congress to Dedicate Arthritis Research Funding to Help Military Service Members

From the College  |  Issue: February 2017  |  February 14, 2017

In 2016, the ACR and the Arthritis Foundation teamed up to direct $20 million within the Department of Defense’s (DoD’s) Congressionally Directed Medical Research Program (CDMRP) to arthritis treatment and prevention. The CDMRP has millions of research dollars that have not been committed to specific items. In the new appropriations cycle, we are once again asking that $20 million be dedicated to finding more effective ways to treat and prevent arthritis.

Arthritis is the leading cause of disability among U.S. military veterans and the second most common reason for medical discharges from the U.S. armed services after injuries incurred in combat. One in three veterans is diagnosed with arthritis, compared with one in five members of the general U.S. population. Important note: These statistics reflect only doctor-diagnosed arthritis and, in the culture of the armed services where pain is commonly associated with weakness, likely reflects only a fraction of the actual number of U.S. service members suffering from arthritis.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

It is not surprising that arthritis affects so many in the military community. The physical demands of the job lead to high-impact injuries, creating long-term damage to joints, tissue and cartilage. Even basic training activities, such as wearing packs that weigh 100-plus lbs. or jumping from trucks with heavy gear on, can result in injuries that affect service members for the rest of their lives. When such an impact injury results in arthritis and leads to the medical discharge of a service member, it can cost the DoD up to $1 million per individual. This amount reflects the medical care for a discharged member for the rest of their life for which the DoD, and not the Veterans Affairs Administration, is responsible.

Even with epidemic-level rates of arthritis among our service members, the steep financial price to the DoD and the dramatic impact on an individual’s ability to continue to serve and their reduced quality of life, Congress has still not dedicated any funding in the DoD budget to arthritis medical research. A military research ecosystem and patient population provides a unique opportunity to conduct clinical trials, test prevention strategies and explore risk factors associated with arthritis within the closed loop of medical data kept on active duty personnel. Just $20 million in dedicated funding could result in more effective ways to treat and prevent arthritis and help these service members avoid medical discharge, improve the quality of life for our veterans and fund research that could ultimately change the lives of the one in five civilians also suffering from arthritis.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

With a new Congress comes a new Committee on Appropriations and lawmakers in need of education on the College’s policy priorities. Visit the ACR’s Legislative Action Center to send a letter to your representative asking them to support this important research.

Page: 1 2 | Multi-Page
Share: 

Filed under:ConditionsFrom the CollegeResearch Rheum Tagged with:AC&RAdvocacyAmerican College of Rheumatology (ACR)ArthritisCongressFundingpreventionResearchTreatment

Related Articles

    RheumPAC Advocates for Department of Defense Arthritis Research Funding

    August 1, 2019

    The ACR’s nonpartisan political action committee is continuing to advocate for increased defense department funding for rheumatology research. Learn about RheumPAC’s efforts and how you can help.

    RheumPAC Advocates for Dept. of Defense Arthritis Research Funding

    September 17, 2019

    SNeG17 / shutterstock.com RheumPAC is the ACR’s non-partisan political action committee, which promotes the needs of rheumatology providers and patients. Advocacy efforts often focus on legislation to improve the day-to-day clinical care of rheumatology patients, such as establishing clinical exceptions to step therapy requirements and reforming the prior authorization process. In addition, the ACR and…

    Arthritis Advocacy Spotlights the Military: Veterans, including a rheumatologist, educate lawmakers about arthritis’ impact & the need for research funding

    February 22, 2019

    On Feb. 13, the ACR co-sponsored Arthritis 101, its biennial arthritis advocacy lunch briefing at the U.S. Capitol, highlighting the disproportionate impact of rheumatic disease on active members of the armed forces and veterans. The event, co-sponsored by the Arthritis Foundation (AF), is part of the ACR’s effort to support inclusion of $20 million in…

    ACR Advocates for Dedicated Department of Defense Arthritis Research Funding

    January 16, 2020

    The ACR and RheumPAC are working to secure an annual allocation of $20 million dedicated to research on arthritis prevention and treatment in the Congressionally Directed Medical Research Program budget.

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences